U.S., Nov. 12 -- An application to own the trademark for 'ARALINQ' has been filed on Oct. 16, 2024.
Owner(s):
Araris Biotech AG; Riedhofstrasse 11, , SWITZERLAND
Goods and/or Services:
For: Pharmaceutical products namely, pharmaceutical preparations for the treatment of oncology, immunology, inflammation, infectious diseases, cardiovascular and metabolism diseases; medical preparations for the treatment of oncology, immunology, inflammation, infectious diseases, cardiovascular and metabolism diseases; pharmaceuticals and medical preparations in the field of cancer therapy; biopharmaceuticals and medical preparations in the field of active antibody conjugates for the treatment of oncology, immunology, inflammation, infectious diseases, c...